The health science business owned by Nestlé (VTX:NESN) said yesterday that it agreed to a staged acquisition of Phagenesis and its device for treating patients who can’t swallow. The deal calls for an unspecified up-front payment and a series of milestones pegged to development programs in the U.S. and Europe for the Phagenyx device, which […]
Neuromodulation/Neurostimulation
Study: Respicardia neurostim implant shows promise in treating central sleep apnea
An implanted neurostimulator developed by Respicardia has been shown to significantly improve symptoms of central sleep apnea without serious side effects, according to a new study from the Ohio State University. Data from the study was presented at the European Society of Cardiology Congress in Rome and was published today in The Lancet. Central sleep […]
Synapse Biomedical wins VA nod for NeuRx diaphragm pacing system
Synapse Biomedical said today it won a GSA schedule 65IIA contract which will allow it to supply its NeuRX diaphragm pacing system to Veterans Affairs hospitals. The Oberlin, Ohio-based company said the approval will allow it to place its NeuRx device, designed to provide electrical stimulation to the muscles and nerves of the diaphragm, in to […]
CVRx raises $113m Series G for Barostim Neo trial
CVRx said today that it raised a $113 million funding round it plans to use to complete a pivotal clinical trial of its Barostim Neo neurostimulation device for treating heart failure. The round consists of a $93 million equity round and a $20 million debt facility, the Minneapolis-based company said. CVRx, which reported raising $46.5 million in a […]
ElectroCore raises $1.5m
ElectroCore raised $1.5 million in a new round of debt financing, according to an SEC filing posted today. ElectroCore is developing a range of non-invasive vagus nerve stimulation for the treatment of a number of conditions in neurology, psychiatry, gastroenterology and other fields, according to the company’s website. Initial focus for the company is a […]
Medtronic wins CE Mark for SureTune2 DBS software
Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for the SureTune2 software used with its deep-brain stimulation devices. The software is designed to allow physicians to fine-tune patients’ therapy “by visualizing patient-specific information in one comprehensive view including anatomy, physiology, and calculated stimulation field,” the Fridley, Minn.-based company said. “Medtronic […]
Verily, GlaxoSmithKline partner to form $713m joint Galvani Bioelectronics
GlaxoSmithKline (NYSE:GSK) said today it is partnering with Google‘s (NSDQ:GOOG) Verily to form Galvani Bioelectronics, a new firm focused on bioelectronic medicine. Bioelectronic medicine operates around using miniaturized, implantable devices, much like neuromodulation devices, designed to modify electrical signals through nerves for a variety of different effects, including pain relief and chronic condition management, the company […]
SPR Therapeutics wins FDA nod for peripheral nerve stim pain relief device
Pain management company SPR Therapeutics yesterday said it won FDA 510(k) clearance for its Sprint peripheral nerve stimulation system designed to provide chronic pain relief. The Cleveland, Ohio-based company touted the Sprint system as the 1st reversible and minimally-invasive PNS to win FDA clearance for treating chronic and acute pain, including post-operative and post-traumatic pain. […]
Boston Scientific acquires RFA manufacturer Cosman Medical
Boston Scientific (NYSE:BSX) said today that it picked up Burlington, Mass.-based radiofrequency ablation company Cosman Medical for an undisclosed amount. Cosman Medical’s team and products will be folded into Boston Scientific’s neuromodulation business, the company said. “This acquisition is a natural extension of our current product portfolio and will help us provide physicians and patients more options […]
Relievant Medsystems wins FDA clearance for Intracept ablation device for low back pain
Relievant Medsystems said today it won FDA 510(k) clearance for its Intracept intraosseous nerve ablation system designed for the treatment of chronic lower back pain. The company touted the system as the 1st specific therapy to relieve chronic lower back pain which has persisted for at least 6 months and not responded to conservative care […]
FDA warns Oscor on process control records
The FDA last month warned contract manufacturer Oscor on its methods for documenting process controls for the catheters and neurostimulation leads it makes, after inspections in February and March turned up a trio of violations. The federal safety watchdog said it inspected Oscor’s plant in Palm Harbor, Fla., where it makes the Adelante Magnum introducer catheter and lead […]